PPT-Assessing Patient-Reported Outcomes of Hemodialysis

Ron D Hays PhD UCLA Division of General Internal Medicine amp Health Services Research drhaysuclaedu December 12 2017 Amgen Thousand Oaks CA Lunch and Learn References Hays R D . Saam. . Morshed. MD, PHD. Orthopaedic . Trauma . Institute. Department of Orthopaedics. SFGH/UCSF, . San Francisco, CA. Brian Cunningham MD. University . of Minnesota. Department of Orthopaedics. Regions Hospital. Outcomes that matter to patients. Mel Tinsley, Program Manager and Dr Hester Wilson, GP. October 2016. Welcome and introductions . PHN staff and guests . The ACI acknowledges the traditional owners of the land on which we meet tonight. We pay our respects to Elders past and present and extend that respect to other Aboriginal peoples present here today.. Sharifi. 95. Hemodialysis access. Irene Turnbull. 1/31/2007. Hemodialysis access. The number of patients with end-stage renal disease (ESRD) in the United States has increased steadily.. 2030: 2.24 million patients with ESRD.. scenario in Nepal. Presentation By. :. Ms. Niru Khatiwada. BSc Nursing (BPKIHS), MN (IOM, TU). Lecturer, Nepal Medical College . (Affiliated to Kathmandu University). Kathmandu, Nepal. 1. OVERVIEW. OVERVIEW. ICH in Asians. Causes of Death in Patients With AF. 2-Year Outcome Data From GARFIELD-AF. Assessing Risk. CHA. 2. DS. 2. -VASc. Event Rates Stratified by CHA. 2. DS. 2. -VASc . Meta-Analysis of NOACs vs Warfarin. Advanced hemodialysis/ Hemodiafiltration based on real-time individualized cardiometabolic measurements Azpiroz-Leehan J., Morón A., Cadena -Méndez M., Sacristán -Rock E., Rosas G., Martínez-Licona with Rubrics. Shara. Skinner & Monica Ketchum. How do you currently use rubrics to assess learning outcomes?. Why use rubrics?. Ease of assessment. One rubric can assess multiple measures or outcomes. GUIDELINES FROM. 5 MEDICAL SOCIETIES IN . NORTH AMERICA, EUROPE AND ASIA. Increased Time and Frequency. OVERVIEW. Proliferation of research about intensive hemodialysis has led to better understanding of when to increase hemodialysis time and frequency. Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. American Journal of Kidney Diseases, Volume 68, Issue 5, S24 - S32.. 2016 Annual Data Report, Vol . 2, ESRD. , . Ch. . 4. 2. Data Source: Special analyses, USRDS ESRD Database. ESRD patients initiating hemodialysis in 2005-2014. Abbreviations: AV, arteriovenous; CMS, Centers for Medicare & Medicaid; ESRD, end-stage renal disease. . MPNs) . Clinical . Trials. Anthony J. Messina. , . MSc. , CCRP . 1,2 . Quentin E. O’Brien. , MPH. 2*. . Vasily Andrianov. , MD. 1. . Keren R. Moss. , MD. 1*. . Laura Vidal. , MD. 2013 The hallenges of Hemodialysis By identifying the potential difficulties associated with tunneled hemodialysis catheters, we can improve blood flow rates and optimize dialysis efficiency.B T Figu ISSN‰㠶2 㠴〸 ⡰物nt) ISSN‱㠰2 㤹73 (online) 2〱9 Instit畴ef⁐hysi潬潧y 潦⁴he⁃zech⁁cademyf⁓ciences,⁐ra杵e, Czech⁒ep畢lic Fax +420 241 062 164, e - mail: physres@ f McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. American Journal of Kidney Diseases, Volume 68, Issue 5, S5 - S14..